ProPhase Labs Revenue and Competitors

The Quigley Corporation manufactures and distributes cold remedy products to the consumer through the over-the-counter marketplace, together with the sale of proprietary health and wellness products through its direct selling subsidiary. The Company's key product Cold-Eeze, a zinc gluconate glycine lozenge, reduces the duration and severity of the common cold symptoms. Cold-Eeze is an established product in the healthcare and cold remedy market. During 2002, approximately 99% of the Company's revenues from Cold-Eeze and Darius International Inc., a wholly owned subsidiary, originated in the United States, with the remainder being attributable to international trade.